Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)
5.16
+0.06 (1.18%)
Sep 30, 2026, 3:04 PM CST
SHE:002370 Revenue
Zhejiang Yatai Pharmaceutical had revenue of 97.95M CNY in the quarter ending June 30, 2026, with 11.91% growth. This brings the company's revenue in the last twelve months to 328.58M, down -2.01% year-over-year. In the year 2025, Zhejiang Yatai Pharmaceutical had annual revenue of 323.14M, down -20.25%.
Revenue (ttm)
328.58M
Revenue Growth
-2.01%
P/S Ratio
11.71
Revenue / Employee
643.02K
Employees
511
Market Cap
3.85B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 323.14M | -82.04M | -20.25% |
| Dec 31, 2024 | 405.17M | -15.47M | -3.68% |
| Dec 31, 2023 | 420.64M | 47.20M | 12.64% |
| Jan 1, 2023 | 373.44M | 58.31M | 18.50% |
| Jan 1, 2022 | 315.13M | -199.75M | -38.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 23.66B |
| Jinhe Biotechnology CO., LTD. | 2.94B |
| Zhejiang Starry Pharmaceutical | 2.46B |
| Huaren Pharmaceutical | 1.30B |
| Tibet Weixinkang Medicine | 1.13B |
| Qianjiang Yongan Pharmaceutical | 979.49M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 737.90M |
| Shanghai Xiao Fang Pharmaceutical | 537.42M |